Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Indices offer a practical way to quantify risk exposure and monitor changes over time, supporting proactive adjustments.
27,018 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
A growing AI marketing platform is courting retail investors with a Reg A+ round at $0.85 per share, pitching a scala...
As brokerages race to attract new investors, free stock promotions are surging in March 2026. This report explains ho...
A family debates paying elderly parents $1,000 a month for babysitting, but opts to fund an investment for the parent...
A DRAM-focused memory ETF delivered triple-digit gains in 2026, outperforming many AI names as investors weighed AI i...
Investors weigh dividend safety check: aristocrats against the broad market as rates shift and AI-driven volatility f...
NVIDIA defies traditional logic by trading on cheaper earnings multiples than its non-tech counterpart while leading ...
As markets enter 2026, a century of stock market data underpins a new wave of strategy. This piece distills three les...
A State Street strategist says the Fed will cut rates three times in 2026, a view that clashes with current market pr...
A growing cadre of investors is exploring whether a Tesla-SpaceX merger could become a true berkshire hathaway inside...
SpaceX is exploring an IPO designed for everyday investors, outlining a plan to list shares and fund its space infras...
Leaders from the G7 unveiled a plan to shrink reliance on China for rare earths, targeting caps by 2030 and rapid mil...